Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001631650-18-000003
Filing Date
2018-11-29
Accepted
2018-11-29 11:04:41
Documents
1
Effectiveness Date
2018-11-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 16394
  Complete submission text file 0001631650-18-000003.txt   17646
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

EIN.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-326810 | Film No.: 181207351
SIC: 2834 Pharmaceutical Preparations